研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2016 年的期刊文章 · 第 21 页
共 1345 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2016-04-08 到 2016-03-30。
按期刊、按主题看 →
Biometrics Missing Data & Measurement Error Latent Variables & Mixtures · 发表于 2016-04-08
Cornelis J. Potgieter, Rubin Wei, Victor Kipnis, Laurence S. Freedman, Raymond J. Carroll
摘要
Summary: For the classical, homoscedastic measurement error model, moment reconstruction (Freedman et al., 2004, 2008) and moment-adjusted imputation (Thomas et al., 2011) are appealing, computationally simple imputation-like methods for general model fitting. Like classical regression calibration, the idea is to replace the unobserved variable subject to measurement error with a proxy that can be used in a variety of analyses. Moment reconstruction and moment-adjusted imputation differ from regression calibration in that they attempt to match multiple features of the latent variable, and also to match some of the latent variable's relationships with the response and additional covariates. In this note, we consider a problem where true exposure is generated by a complex, nonlinear random effects modeling process, and develop analogues of moment reconstruction and moment-adjusted imputation for this case. This general model includes classical measurement errors, Berkson measurement errors, mixtures of Berkson and classical errors and problems that are not measurement error problems, but also cases where the data-generating process for true exposure is a complex, nonlinear random effects modeling process. The methods are illustrated using the National Institutes of Health–AARP Diet and Health Study where the latent variable is a dietary pattern score called the Healthy Eating Index-2005. We also show how our general model includes methods used in radiation epidemiology as a special case. Simulations are used to illustrate the methods.
Biometrics Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2016-04-08
Fang Wan, Wei Liu, Frank Bretz, Yang Han
摘要
Summary: Construction of confidence sets for the optimal factor levels is an important topic in response surfaces methodology. In Wan et al. (2015), an exact confidence set has been provided for a maximum or minimum point (i.e., an optimal factor level) of a univariate polynomial function in a given interval. In this article, the method has been extended to construct an exact confidence set for the optimal factor levels of response surfaces. The construction method is readily applied to many parametric and semiparametric regression models involving a quadratic function. A conservative confidence set has been provided as an intermediate step in the construction of the exact confidence set. Two examples are given to illustrate the application of the confidence sets. The comparison between confidence sets indicates that our exact confidence set is better than the only other confidence set available in the statistical literature that guarantees the confidence level.
Biometrics Bayesian Methods · 发表于 2016-04-08
Gregory Imholte, Raphael Gottardo
摘要
Summary: The peptide microarray immunoassay simultaneously screens sample serum against thousands of peptides, determining the presence of antibodies bound to array probes. Peptide microarrays tiling immunogenic regions of pathogens (e.g., envelope proteins of a virus) are an important high throughput tool for querying and mapping antibody binding. Because of the assay's many steps, from probe synthesis to incubation, peptide microarray data can be noisy with extreme outliers. In addition, subjects may produce different antibody profiles in response to an identical vaccine stimulus or infection, due to variability among subjects’ immune systems. We present a robust Bayesian hierarchical model for peptide microarray experiments, pepBayes, to estimate the probability of antibody response for each subject/peptide combination. Heavy-tailed error distributions accommodate outliers and extreme responses, and tailored random effect terms automatically incorporate technical effects prevalent in the assay. We apply our model to two vaccine trial data sets to demonstrate model performance. Our approach enjoys high sensitivity and specificity when detecting vaccine induced antibody responses. A simulation study shows an adaptive thresholding classification method has appropriate false discovery rate control with high sensitivity, and receiver operating characteristics generated on vaccine trial data suggest that pepBayes clearly separates responses from non-responses.
Biometrics Survey & Sampling · 发表于 2016-04-08
Raphael André Fraser, Stuart R. Lipsitz, Debajyoti Sinha, Garrett M. Fitzmaurice, Yi Pan
摘要
Summary: The ready availability of public-use data from various large national complex surveys has immense potential for the assessment of population characteristics using regression models. Complex surveys can be used to identify risk factors for important diseases such as cancer. Existing statistical methods based on estimating equations and/or utilizing resampling methods are often not valid with survey data due to complex survey design features. That is, stratification, multistage sampling, and weighting. In this article, we accommodate these design features in the analysis of highly skewed response variables arising from large complex surveys. Specifically, we propose a double-transform-both-sides (DTBS)'based estimating equations approach to estimate the median regression parameters of the highly skewed response; the DTBS approach applies the same Box–Cox type transformation twice to both the outcome and regression function. The usual sandwich variance estimate can be used in our approach, whereas a resampling approach would be needed for a pseudo-likelihood based on minimizing absolute deviations (MAD). Furthermore, the approach is relatively robust to the true underlying distribution, and has much smaller mean square error than a MAD approach. The method is motivated by an analysis of laboratory data on urinary iodine (UI) concentration from the National Health and Nutrition Examination Survey.
Biometrics Causal Inference Missing Data & Measurement Error · 发表于 2016-04-08
Melanie Prague, Rui Wang, Alisa Stephens, Eric Tchetgen Tchetgen, Victor DeGruttola
摘要
Summary: Semi-parametric methods are often used for the estimation of intervention effects on correlated outcomes in cluster-randomized trials (CRTs). When outcomes are missing at random (MAR), Inverse Probability Weighted (IPW) methods incorporating baseline covariates can be used to deal with informative missingness. Also, augmented generalized estimating equations (AUG) correct for imbalance in baseline covariates but need to be extended for MAR outcomes. However, in the presence of interactions between treatment and baseline covariates, neither method alone produces consistent estimates for the marginal treatment effect if the model for interaction is not correctly specified. We propose an AUG–IPW estimator that weights by the inverse of the probability of being a complete case and allows different outcome models in each intervention arm. This estimator is doubly robust (DR); it gives correct estimates whether the missing data process or the outcome model is correctly specified. We consider the problem of covariate interference which arises when the outcome of an individual may depend on covariates of other individuals. When interfering covariates are not modeled, the DR property prevents bias as long as covariate interference is not present simultaneously for the outcome and the missingness. An R package is developed implementing the proposed method. An extensive simulation study and an application to a CRT of HIV risk reduction-intervention in South Africa illustrate the method.
SMMR Causal Inference · 发表于 2016-04-07
Luca Salmasi, Enrico Capobianco
摘要
Precision medicine presents various methodological challenges whose assessment requires the consideration of multiple factors. In particular, the data multitude in the Electronic Health Records poses interoperability issues and requires novel inference strategies. A problem, though apparently a paradox, is that highly specific treatments and a variety of outcomes may hardly match with consistent observations (i.e., large samples). Why is it the case? Owing to the heterogeneity of Electronic Health Records, models for the evaluation of treatment effects need to be selected, and in some cases, the use of instrumental variables might be necessary. We studied the recently defined person-centered treatment effects in cancer and C-section contexts from Electronic Health Record sources and identified as an instrument the distance of patients from hospitals. We present first the rationale for using such instrument and then its model implementation. While for cancer patients consideration of distance turns out to be a penalty, implying a negative effect on the probability of receiving surgery, a positive effect is instead found in C-section due to higher propensity of scheduling delivery. Overall, the estimated person-centered treatment effects reveal a high degree of heterogeneity, whose interpretation remains context-dependent. With regard to the use of instruments in light of our two case studies, our suggestion is that this process requires ad hoc variable selection for both covariates and instruments and additional testing to ensure validity.
SiM Clinical Trials Bayesian Methods · 发表于 2016-04-07
Mourad Tighiouart, Quanlin Li, André Rogatko
摘要
We present a cancer phase I clinical trial design of a combination of two drugs with the goal of estimating the maximum tolerated dose curve in the two‐dimensional Cartesian plane. A parametric model is used to describe the relationship between the doses of the two agents and the probability of dose limiting toxicity. The model is re‐parameterized in terms of the probabilities of toxicities at dose combinations corresponding to the minimum and maximum doses available in the trial and the interaction parameter. Trial design proceeds using cohorts of two patients receiving doses according to univariate escalation with overdose control (EWOC), where at each stage of the trial, we seek a dose of one agent using the current posterior distribution of the MTD of this agent given the current dose of the other agent. The maximum tolerated dose curve is estimated as a function of Bayes estimates of the model parameters. Performance of the trial is studied by evaluating its design operating characteristics in terms of safety of the trial and percent of dose recommendation at dose combination neighborhoods around the true MTD curve and under model misspecifications for the true dose–toxicity relationship. The method is further extended to accommodate discrete dose combinations and compared with previous approaches under several scenarios. Copyright © 2016 John Wiley & Sons, Ltd.
SiM Longitudinal Data Missing Data & Measurement Error · 发表于 2016-04-05
Alejandro Salazar, Begoña Ojeda, María Dueñas, Fernando Fernández, Inmaculada Failde
摘要
Missing data are a common problem in clinical and epidemiological research, especially in longitudinal studies. Despite many methodological advances in recent decades, many papers on clinical trials and epidemiological studies do not report using principled statistical methods to accommodate missing data or use ineffective or inappropriate techniques. Two refined techniques are presented here: generalized estimating equations (GEEs) and weighted generalized estimating equations (WGEEs). These techniques are an extension of generalized linear models to longitudinal or clustered data, where observations are no longer independent. They can appropriately handle missing data when the missingness is completely at random (GEE and WGEE) or at random (WGEE) and do not require the outcome to be normally distributed. Our aim is to describe and illustrate with a real example, in a simple and accessible way to researchers, these techniques for handling missing data in the context of longitudinal studies subject to dropout and show how to implement them in R. We apply them to assess the evolution of health‐related quality of life in coronary patients in a data set subject to dropout. Copyright © 2016 John Wiley & Sons, Ltd.
SiM Diagnostics & Prediction Nonparametric & Semiparametric · 发表于 2016-04-05
Youyi Fong, Shuxin Yin, Ying Huang
摘要
In biomedical studies, it is often of interest to classify/predict a subject's disease status based on a variety of biomarker measurements. A commonly used classification criterion is based on area under the receiver operating characteristic curve (AUC). Many methods have been proposed to optimize approximated empirical AUC criteria, but there are two limitations to the existing methods. First, most methods are only designed to find the best linear combination of biomarkers, which may not perform well when there is strong nonlinearity in the data. Second, many existing linear combination methods use gradient‐based algorithms to find the best marker combination, which often result in suboptimal local solutions. In this paper, we address these two problems by proposing a new kernel‐based AUC optimization method called ramp AUC (RAUC). This method approximates the empirical AUC loss function with a ramp function and finds the best combination by a difference of convex functions algorithm. We show that as a linear combination method, RAUC leads to a consistent and asymptotically normal estimator of the linear marker combination when the data are generated from a semiparametric generalized linear model, just as the smoothed AUC method. Through simulation studies and real data examples, we demonstrate that RAUC outperforms smooth AUC in finding the best linear marker combinations, and can successfully capture nonlinear pattern in the data to achieve better classification performance. We illustrate our method with a dataset from a recent HIV vaccine trial. Copyright © 2016 John Wiley & Sons, Ltd.
SiM Survival Analysis · 发表于 2016-04-05
Pamela A. Shaw, Michael P. Fay
摘要
In many clinical settings, improving patient survival is of interest but a practical surrogate, such as time to disease progression, is instead used as a clinical trial's primary endpoint. A time‐to‐first endpoint (e.g., death or disease progression) is commonly analyzed but may not be adequate to summarize patient outcomes if a subsequent event contains important additional information. We consider a surrogate outcome very generally as one correlated with the true endpoint of interest. Settings of interest include those where the surrogate indicates a beneficial outcome so that the usual time‐to‐first endpoint of death or surrogate event is nonsensical. We present a new two‐sample test for bivariate, interval‐censored time‐to‐event data, where one endpoint is a surrogate for the second, less frequently observed endpoint of true interest. This test examines whether patient groups have equal clinical severity. If the true endpoint rarely occurs, the proposed test acts like a weighted logrank test on the surrogate; if it occurs for most individuals, then our test acts like a weighted logrank test on the true endpoint. If the surrogate is a useful statistical surrogate, our test can have better power than tests based on the surrogate that naively handles the true endpoint. In settings where the surrogate is not valid (treatment affects the surrogate but not the true endpoint), our test incorporates the information regarding the lack of treatment effect from the observed true endpoints and hence is expected to have a dampened treatment effect compared with tests based on the surrogate alone. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
SiM Bayesian Methods · 发表于 2016-04-05
Andrew S. Gordon, Adele H. Marshall, Karen J. Cairns
摘要
The number of elderly patients requiring hospitalisation in Europe is rising. With a greater proportion of elderly people in the population comes a greater demand for health services and, in particular, hospital care. Thus, with a growing number of elderly patients requiring hospitalisation competing with non‐elderly patients for a fixed (and in some cases, decreasing) number of hospital beds, this results in much longer waiting times for patients, often with a less satisfactory hospital experience. However, if a better understanding of the recurring nature of elderly patient movements between the community and hospital can be developed, then it may be possible for alternative provisions of care in the community to be put in place and thus prevent readmission to hospital. The research in this paper aims to model the multiple patient transitions between hospital and community by utilising a mixture of conditional Coxian phase‐type distributions that incorporates Bayes' theorem. For the purpose of demonstration, the results of a simulation study are presented and the model is applied to hospital readmission data from the Lombardy region of Italy. Copyright © 2016 John Wiley & Sons, Ltd.
Biometrics Latent Variables & Mixtures · 发表于 2016-04-04
Linda M. Haines
摘要
Summary: The focus of this article is on the nature of the likelihood associated with N-mixture models for repeated count data. It is shown that the infinite sum embedded in the likelihood associated with the Poisson mixing distribution can be expressed in terms of a hypergeometric function and, thence, in closed form. The resultant expression for the likelihood can be readily computed to a high degree of accuracy and is algebraically tractable. Specifically, the likelihood equations can be simplified to some advantage, the concentrated likelihood in the probability of detection formulated and problematic cases identified. The results are illustrated by means of a simulation study and a real world example. The study is extended to N-mixture models with a negative binomial mixing distribution and results similar to those for the Poisson case obtained. N-mixture models with mixing distributions which accommodate excess zeros and, separately, with a beta-binomial distribution rather than a binomial used to model the intra-site counts are also investigated. However the results for these settings, while computationally attractive, do not provide insight into the nature of the maximum likelihood estimates.
SiM Missing Data & Measurement Error Bayesian Methods Longitudinal Data · 发表于 2016-04-04
Nicole S. Erler, Dimitris Rizopoulos, Joost van Rosmalen, Vincent W. V. Jaddoe, Oscar H. Franco, Emmanuel M. E. H. Lesaffre
摘要
Incomplete data are generally a challenge to the analysis of most large studies. The current gold standard to account for missing data is multiple imputation, and more specifically multiple imputation with chained equations (MICE). Numerous studies have been conducted to illustrate the performance of MICE for missing covariate data. The results show that the method works well in various situations. However, less is known about its performance in more complex models, specifically when the outcome is multivariate as in longitudinal studies. In current practice, the multivariate nature of the longitudinal outcome is often neglected in the imputation procedure, or only the baseline outcome is used to impute missing covariates. In this work, we evaluate the performance of MICE using different strategies to include a longitudinal outcome into the imputation models and compare it with a fully Bayesian approach that jointly imputes missing values and estimates the parameters of the longitudinal model. Results from simulation and a real data example show that MICE requires the analyst to correctly specify which components of the longitudinal process need to be included in the imputation models in order to obtain unbiased results. The full Bayesian approach, on the other hand, does not require the analyst to explicitly specify how the longitudinal outcome enters the imputation models. It performed well under different scenarios. Copyright © 2016 John Wiley & Sons, Ltd.
SMMR Bayesian Methods · 发表于 2016-04-04
Junsheng Ma, Wenyaw Chan, Barbara C Tilley
摘要
Continuous time Markov chain models are frequently employed in medical research to study the disease progression but are rarely applied to the transtheoretical model, a psychosocial model widely used in the studies of health-related outcomes. The transtheoretical model often includes more than three states and conceptually allows for all possible instantaneous transitions (referred to as general continuous time Markov chain). This complicates the likelihood function because it involves calculating a matrix exponential that may not be simplified for general continuous time Markov chain models. We undertook a Bayesian approach wherein we numerically evaluated the likelihood using ordinary differential equation solvers available from the gnu scientific library. We compared our Bayesian approach with the maximum likelihood method implemented with the R package MSM. Our simulation study showed that the Bayesian approach provided more accurate point and interval estimates than the maximum likelihood method, especially in complex continuous time Markov chain models with five states. When applied to data from a four-state transtheoretical model collected from a nutrition intervention study in the next step trial, we observed results consistent with the results of the simulation study. Specifically, the two approaches provided comparable point estimates and standard errors for most parameters, but the maximum likelihood offered substantially smaller standard errors for some parameters. Comparable estimates of the standard errors are obtainable from package MSM, which works only when the model estimation algorithm converges.
AoS Other · 发表于 2016-04-01
Alexander R. Luedtke, Mark J. van der Laan
摘要
We consider challenges that arise in the estimation of the mean outcome under an optimal individualized treatment strategy defined as the treatment rule that maximizes the population mean outcome, where the candidate treatment rules are restricted to depend on baseline covariates. We prove a necessary and sufficient condition for the pathwise differentiability of the optimal value, a key condition needed to develop a regular and asymptotically linear (RAL) estimator of the optimal value. The stated condition is slightly more general than the previous condition implied in the literature. We then describe an approach to obtain root-$n$ rate confidence intervals for the optimal value even when the parameter is not pathwise differentiable. We provide conditions under which our estimator is RAL and asymptotically efficient when the mean outcome is pathwise differentiable. We also outline an extension of our approach to a multiple time point problem. All of our results are supported by simulations.
Biometrics Diagnostics & Prediction Survival Analysis · 发表于 2016-04-01
Rebecca Payne, Ming Yang, Yingye Zheng, Majken K. Jensen, Tianxi Cai
摘要
Summary: Identification of novel biomarkers for risk prediction is important for disease prevention and optimal treatment selection. However, studies aiming to discover which biomarkers are useful for risk prediction often require the use of stored biological samples from large assembled cohorts, and thus the depletion of a finite and precious resource. To make efficient use of such stored samples, two-phase sampling designs are often adopted as resource-efficient sampling strategies, especially when the outcome of interest is rare. Existing methods for analyzing data from two-phase studies focus primarily on single marker analysis or fitting the Cox regression model to combine information from multiple markers. However, the Cox model may not fit the data well. Under model misspecification, the composite score derived from the Cox model may not perform well in predicting the outcome. Under a general two-phase stratified cohort sampling design, we present a novel approach to combining multiple markers to optimize prediction by fitting a flexible nonparametric transformation model. Using inverse probability weighting to account for the outcome-dependent sampling, we propose to estimate the model parameters by maximizing an objective function which can be interpreted as a weighted C-statistic for survival outcomes. Regardless of model adequacy, the proposed procedure yields a sensible composite risk score for prediction. A major obstacle for making inference under two phase studies is due to the correlation induced by the finite population sampling, which prevents standard inference procedures such as the bootstrap from being used for variance estimation. We propose a resampling procedure to derive valid confidence intervals for the model parameters and the C-statistic accuracy measure. We illustrate the new methods with simulation studies and an analysis of a two-phase study of high-density lipoprotein cholesterol (HDL-C) subtypes for predicting the risk of coronary heart disease.
Biometrics Genetics & Omics · 发表于 2016-04-01
Roger S. Zoh, Bani Mallick, Ivan Ivanov, Veera Baladandayuthapani, Ganiraju Manyam, Robert S. Chapkin, Johanna W. Lampe, Raymond J. Carroll
摘要
Summary: Most cancer research now involves one or more assays profiling various biological molecules, e.g., messenger RNA and micro RNA, in samples collected on the same individuals. The main interest with these genomic data sets lies in the identification of a subset of features that are active in explaining the dependence between platforms. To quantify the strength of the dependency between two variables, correlation is often preferred. However, expression data obtained from next-generation sequencing platforms are integer with very low counts for some important features. In this case, the sample Pearson correlation is not a valid estimate of the true correlation matrix, because the sample correlation estimate between two features/variables with low counts will often be close to zero, even when the natural parameters of the Poisson distribution are, in actuality, highly correlated. We propose a model-based approach to correlation estimation between two non-normal data sets, via a method we call Probabilistic Correlations ANalysis, or PCAN. PCAN takes into consideration the distributional assumption about both data sets and suggests that correlations estimated at the model natural parameter level are more appropriate than correlations estimated directly on the observed data. We demonstrate through a simulation study that PCAN outperforms other standard approaches in estimating the true correlation between the natural parameters. We then apply PCAN to the joint analysis of a microRNA (miRNA) and a messenger RNA (mRNA) expression data set from a squamous cell lung cancer study, finding a large number of negative correlation pairs when compared to the standard approaches.
AoS Other · 发表于 2016-04-01
Xianchao Xie, S. C. Kou, Lawrence Brown
摘要
This paper discusses the simultaneous inference of mean parameters in a family of distributions with quadratic variance function. We first introduce a class of semiparametric/parametric shrinkage estimators and establish their asymptotic optimality properties. Two specific cases, the location-scale family and the natural exponential family with quadratic variance function, are then studied in detail. We conduct a comprehensive simulation study to compare the performance of the proposed methods with existing shrinkage estimators. We also apply the method to real data and obtain encouraging results.
AoS Other · 发表于 2016-04-01
Tony Cai, Donggyu Kim, Yazhen Wang, Ming Yuan, Harrison H. Zhou
摘要
Quantum state tomography aims to determine the state of a quantum system as represented by a density matrix. It is a fundamental task in modern scientific studies involving quantum systems. In this paper, we study estimation of high-dimensional density matrices based on Pauli measurements. In particular, under appropriate notion of sparsity, we establish the minimax optimal rates of convergence for estimation of the density matrix under both the spectral and Frobenius norm losses; and show how these rates can be achieved by a common thresholding approach. Numerical performance of the proposed estimator is also investigated.
AoS Nonparametric & Semiparametric · 发表于 2016-04-01
Yen-Chi Chen, Christopher R. Genovese, Ryan J. Tibshirani, Larry Wasserman
摘要
Modal regression estimates the local modes of the distribution of $Y$ given $X=x$, instead of the mean, as in the usual regression sense, and can hence reveal important structure missed by usual regression methods. We study a simple nonparametric method for modal regression, based on a kernel density estimate (KDE) of the joint distribution of $Y$ and $X$. We derive asymptotic error bounds for this method, and propose techniques for constructing confidence sets and prediction sets. The latter is used to select the smoothing bandwidth of the underlying KDE. The idea behind modal regression is connected to many others, such as mixture regression and density ridge estimation, and we discuss these ties as well.
AoS Nonparametric & Semiparametric High-Dimensional · 发表于 2016-04-01
Jinyuan Chang, Cheng Yong Tang, Yichao Wu
摘要
We consider an independence feature screening technique for identifying explanatory variables that locally contribute to the response variable in high-dimensional regression analysis. Without requiring a specific parametric form of the underlying data model, our approach accommodates a wide spectrum of nonparametric and semiparametric model families. To detect the local contributions of explanatory variables, our approach constructs empirical likelihood locally in conjunction with marginal nonparametric regressions. Since our approach actually requires no estimation, it is advantageous in scenarios such as the single-index models where even specification and identification of a marginal model is an issue. By automatically incorporating the level of variation of the nonparametric regression and directly assessing the strength of data evidence supporting local contribution from each explanatory variable, our approach provides a unique perspective for solving feature screening problems. Theoretical analysis shows that our approach can handle data dimensionality growing exponentially with the sample size. With extensive theoretical illustrations and numerical examples, we show that the local independence screening approach performs promisingly.
AoS High-Dimensional · 发表于 2016-04-01
Monika Bhattacharjee, Arup Bose
摘要
The existence of limiting spectral distribution (LSD) of $\hat{\Gamma}_{u}+\hat{\Gamma}_{u}^{*}$, the symmetric sum of the sample autocovariance matrix $\hat{\Gamma}_{u}$ of order $u$, is known when the observations are from an infinite dimensional vector linear process with appropriate (strong) assumptions on the coefficient matrices. Under significantly weaker conditions, we prove, in a unified way, that the LSD of any symmetric polynomial in these matrices such as $\hat{\Gamma}_{u}+\hat{\Gamma}_{u}^{*}$, $\hat{\Gamma}_{u}\hat{\Gamma}_{u}^{*}$, $\hat{\Gamma}_{u}\hat{\Gamma}_{u}^{*}+\hat{\Gamma}_{k}\hat{\Gamma}_{k}^{*}$ exist. Our approach is through the more intuitive algebraic method of free probability in conjunction with the method of moments. Thus, we are able to provide a general description for the limits in terms of some freely independent variables. All the previous results follow as special cases. We suggest statistical uses of these LSD and related results in order determination and white noise testing.
AoS High-Dimensional · 发表于 2016-04-01
Jonathan E. Taylor, Joshua R. Loftus, Ryan J. Tibshirani
摘要
We derive an exact $p$-value for testing a global null hypothesis in a general adaptive regression setting. Our approach uses the Kac–Rice formula [as described in Random Fields and Geometry (2007) Springer, New York] applied to the problem of maximizing a Gaussian process. The resulting test statistic has a known distribution in finite samples, assuming Gaussian errors. We examine this test statistic in the case of the lasso, group lasso, principal components and matrix completion problems. For the lasso problem, our test relates closely to the recently proposed covariance test of Lockhart et al. [Ann. Statist. (2004) 42 413–468]. In a few specific settings, our proposed tests will be less powerful than other previously known (and well-established) tests. However, it should be noted that the real strength of our proposal here is its generality. We provide a framework for constructing valid tests across a wide class of regularized regression problems, and as far as we can tell, such a unified view was not possible before this work.
AoS High-Dimensional Optimization & Learning Theory · 发表于 2016-04-01
Hongcheng Liu, Tao Yao, Runze Li
摘要
This paper is concerned with solving nonconvex learning problems with folded concave penalty. Despite that their global solutions entail desirable statistical properties, they lack optimization techniques that guarantee global optimality in a general setting. In this paper, we show that a class of nonconvex learning problems are equivalent to general quadratic programs. This equivalence facilitates us in developing mixed integer linear programming reformulations, which admit finite algorithms that find a provably global optimal solution. We refer to this reformulation-based technique as the mixed integer programming-based global optimization (MIPGO). To our knowledge, this is the first global optimization scheme with a theoretical guarantee for folded concave penalized nonconvex learning with the SCAD penalty [J. Amer. Statist. Assoc. 96 (2001) 1348–1360] and the MCP penalty [Ann. Statist. 38 (2001) 894–942]. Numerical results indicate a significant outperformance of MIPGO over the state-of-the-art solution scheme, local linear approximation and other alternative solution techniques in literature in terms of solution quality.
AoS Other · 发表于 2016-04-01
Sumit Mukherjee
摘要
Asymptotics of the normalizing constant are computed for a class of one parameter exponential families on permutations which include Mallows models with Spearmans’s Footrule and Spearman’s Rank Correlation Statistic. The MLE and a computable approximation of the MLE are shown to be consistent. The pseudo-likelihood estimator of Besag is shown to be $\sqrt{n}$-consistent. An iterative algorithm (IPFP) is proved to converge to the limiting normalizing constant. The Mallows model with Kendall’s tau is also analyzed to demonstrate the flexibility of the tools of this paper.
AoS High-Dimensional · 发表于 2016-04-01
T. Tony Cai, Weidong Liu, Harrison H. Zhou
摘要
Precision matrix is of significant importance in a wide range of applications in multivariate analysis. This paper considers adaptive minimax estimation of sparse precision matrices in the high dimensional setting. Optimal rates of convergence are established for a range of matrix norm losses. A fully data driven estimator based on adaptive constrained $\ell_{1}$ minimization is proposed and its rate of convergence is obtained over a collection of parameter spaces. The estimator, called ACLIME, is easy to implement and performs well numerically. A major step in establishing the minimax rate of convergence is the derivation of a rate-sharp lower bound. A “two-directional” lower bound technique is applied to obtain the minimax lower bound. The upper and lower bounds together yield the optimal rates of convergence for sparse precision matrix estimation and show that the ACLIME estimator is adaptively minimax rate optimal for a collection of parameter spaces and a range of matrix norm losses simultaneously.
AoS Latent Variables & Mixtures · 发表于 2016-04-01
Stéphane Bonhomme, Koen Jochmans, Jean-Marc Robin
摘要
A constructive proof of identification of multilinear decompositions of multiway arrays is presented. It can be applied to show identification in a variety of multivariate latent structures. Examples are finite-mixture models and hidden Markov models. The key step to show identification is the joint diagonalization of a set of matrices in the same nonorthogonal basis. An estimator of the latent-structure model may then be based on a sample version of this joint-diagonalization problem. Algorithms are available for computation and we derive distribution theory. We further develop asymptotic theory for orthogonal-series estimators of component densities in mixture models and emission densities in hidden Markov models.
Biometrics Bayesian Methods Diagnostics & Prediction · 发表于 2016-04-01
Erin E. Gabriel, Michael J. Daniels, M. Elizabeth Halloran
摘要
Summary: An intermediate response measure that accurately predicts efficacy in a new setting can reduce trial cost and time to product licensure. In this article, we define a trial level general surrogate, which is an intermediate response that can be used to accurately predict efficacy in a new setting. Methods for evaluating general surrogates have been developed previously. Many methods in the literature use trial level intermediate responses for prediction. However, all existing methods focus on surrogate evaluation and prediction in new settings, rather than comparison of candidate general surrogates, and few formalize the use of cross validation to quantify the expected prediction error. Our proposed method uses Bayesian non-parametric modeling and cross-validation to estimate the absolute prediction error for use in evaluating and comparing candidate trial level general surrogates. Simulations show that our method performs well across a variety of scenarios. We use our method to evaluate and to compare candidate trial level general surrogates in several multi-national trials of a pentavalent rotavirus vaccine. We identify at least one immune measure that has potential value as a trial level general surrogate and use it to predict efficacy in a new trial where the clinical outcome was not measured.
AoS Optimization & Learning Theory High-Dimensional · 发表于 2016-04-01
Dimitris Bertsimas, Angela King, Rahul Mazumder
摘要
In the period 1991–2015, algorithmic advances in Mixed Integer Optimization (MIO) coupled with hardware improvements have resulted in an astonishing 450 billion factor speedup in solving MIO problems. We present a MIO approach for solving the classical best subset selection problem of choosing $k$ out of $p$ features in linear regression given $n$ observations. We develop a discrete extension of modern first-order continuous optimization methods to find high quality feasible solutions that we use as warm starts to a MIO solver that finds provably optimal solutions. The resulting algorithm (a) provides a solution with a guarantee on its suboptimality even if we terminate the algorithm early, (b) can accommodate side constraints on the coefficients of the linear regression and (c) extends to finding best subset solutions for the least absolute deviation loss function. Using a wide variety of synthetic and real datasets, we demonstrate that our approach solves problems with $n$ in the 1000s and $p$ in the 100s in minutes to provable optimality, and finds near optimal solutions for $n$ in the 100s and $p$ in the 1000s in minutes. We also establish via numerical experiments that the MIO approach performs better than Lasso and other popularly used sparse learning procedures, in terms of achieving sparse solutions with good predictive power.
AoS Bayesian Methods Nonparametric & Semiparametric High-Dimensional · 发表于 2016-04-01
Yun Yang, David B. Dunson
摘要
There is increasing interest in the problem of nonparametric regression with high-dimensional predictors. When the number of predictors $D$ is large, one encounters a daunting problem in attempting to estimate a $D$-dimensional surface based on limited data. Fortunately, in many applications, the support of the data is concentrated on a $d$-dimensional subspace with $d\ll D$. Manifold learning attempts to estimate this subspace. Our focus is on developing computationally tractable and theoretically supported Bayesian nonparametric regression methods in this context. When the subspace corresponds to a locally-Euclidean compact Riemannian manifold, we show that a Gaussian process regression approach can be applied that leads to the minimax optimal adaptive rate in estimating the regression function under some conditions. The proposed model bypasses the need to estimate the manifold, and can be implemented using standard algorithms for posterior computation in Gaussian processes. Finite sample performance is illustrated in a data analysis example.
AoS Optimization & Learning Theory · 发表于 2016-04-01
Vianney Perchet, Philippe Rigollet, Sylvain Chassang, Erik Snowberg
摘要
Motivated by practical applications, chiefly clinical trials, we study the regret achievable for stochastic bandits under the constraint that the employed policy must split trials into a small number of batches. We propose a simple policy, and show that a very small number of batches gives close to minimax optimal regret bounds. As a byproduct, we derive optimal policies with low switching cost for stochastic bandits.
AoS Spatial & Time Series · 发表于 2016-04-01
Victor M. Panaretos, Yoav Zemel
摘要
We develop a canonical framework for the study of the problem of registration of multiple point processes subjected to warping, known as the problem of separation of amplitude and phase variation. The amplitude variation of a real random function $\{Y(x):x\in[0,1]\}$ corresponds to its random oscillations in the $y$-axis, typically encapsulated by its (co)variation around a mean level. In contrast, its phase variation refers to fluctuations in the $x$-axis, often caused by random time changes. We formalise similar notions for a point process, and nonparametrically separate them based on realisations of i.i.d. copies $\{\Pi_{i}\}$ of the phase-varying point process. A key element in our approach is to demonstrate that when the classical phase variation assumptions of Functional Data Analysis (FDA) are applied to the point process case, they become equivalent to conditions interpretable through the prism of the theory of optimal transportation of measure. We demonstrate that these induce a natural Wasserstein geometry tailored to the warping problem, including a formal notion of bias expressing over-registration. Within this framework, we construct nonparametric estimators that tend to avoid over-registration in finite samples. We show that they consistently estimate the warp maps, consistently estimate the structural mean, and consistently register the warped point processes, even in a sparse sampling regime. We also establish convergence rates, and derive $\sqrt{n}$-consistency and a central limit theorem in the Cox process case under dense sampling, showing rate optimality of our structural mean estimator in that case.
SiM Clinical Trials Diagnostics & Prediction Missing Data & Measurement Error · 发表于 2016-03-31
Peter B. Gilbert, Holly E. Janes, Yunda Huang
摘要
In a randomized controlled clinical trial that assesses treatment efficacy, a common objective is to assess the association of a measured biomarker response endpoint with the primary study endpoint in the active treatment group, using a case‐cohort, case‐control, or two‐phase sampling design. Methods for power and sample size calculations for such biomarker association analyses typically do not account for the level of treatment efficacy, precluding interpretation of the biomarker association results in terms of biomarker effect modification of treatment efficacy, with detriment that the power calculations may tacitly and inadvertently assume that the treatment harms some study participants. We develop power and sample size methods accounting for this issue, and the methods also account for inter‐individual variability of the biomarker that is not biologically relevant (e.g., due to technical measurement error). We focus on a binary study endpoint and on a biomarker subject to measurement error that is normally distributed or categorical with two or three levels. We illustrate the methods with preventive HIV vaccine efficacy trials and include an R package implementing the methods. Copyright © 2016 John Wiley & Sons, Ltd.
SiM Bayesian Methods Networks & Graphs Meta-Analysis & Data Integration · 发表于 2016-03-31
Hong Zhao, James S. Hodges, Haijun Ma, Qi Jiang, Bradley P. Carlin
摘要
Network meta-analysis (NMA), also known as multiple treatment comparisons, is commonly used to incorporate direct and indirect evidence comparing treatments. With recent advances in methods and software, Bayesian approaches to NMA have become quite popular and allow models of previously unanticipated complexity. However, when direct and indirect evidence differ in an NMA, the model is said to suffer from inconsistency. Current inconsistency detection in NMA is usually based on contrast-based (CB) models; however, this approach has certain limitations. In this work, we propose an arm-based random effects model, where we detect discrepancy of direct and indirect evidence for comparing two treatments using the fixed effects in the model while flagging extreme trials using the random effects. We define discrepancy factors to characterize evidence of inconsistency for particular treatment comparisons, which is novel in NMA research. Our approaches permit users to address issues previously tackled via CB models. We compare sources of inconsistency identified by our approach and existing loop-based CB methods using real and simulated datasets and demonstrate that our methods can offer powerful inconsistency detection. Copyright © 2016 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Survival Analysis Diagnostics & Prediction · 发表于 2016-03-31
Andrew C. Titman
摘要
The incremental life expectancy, defined as the difference in mean survival times between two treatment groups, is a crucial quantity of interest in cost-effectiveness analyses. Usually, this quantity is very difficult to estimate from censored survival data with a limited follow-up period. The paper develops estimation procedures for a time-shift survival model that, provided model assumptions are met, gives a reliable estimate of incremental life expectancy without extrapolation beyond the study period. Methods for inference are developed both for individual patient data and when only published Kaplan-Meier curves are available. Through simulation, the estimators are shown to be close to unbiased and constructed confidence intervals are shown to have close to nominal coverage for small to moderate sample sizes. Copyright © 2016 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Survival Analysis Causal Inference Nonparametric & Semiparametric · 发表于 2016-03-31
Jon Arni Steingrimsson, Liqun Diao, Annette M. Molinaro, Robert L. Strawderman
摘要
Estimating a patient's mortality risk is important in making treatment decisions. Survival trees are a useful tool and employ recursive partitioning to separate patients into different risk groups. Existing 'loss based' recursive partitioning procedures that would be used in the absence of censoring have previously been extended to the setting of right censored outcomes using inverse probability censoring weighted estimators of loss functions. In this paper, we propose new 'doubly robust' extensions of these loss estimators motivated by semiparametric efficiency theory for missing data that better utilize available data. Simulations and a data analysis demonstrate strong performance of the doubly robust survival trees compared with previously used methods. Copyright © 2016 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Clinical Trials Survival Analysis · 发表于 2016-03-30
Mohamed Amine Bayar, Gwénaël Le Teuff, Stefan Michiels, Daniel J. Sargent, Marie‐Cécile Le Deley
摘要
Large sample sizes are required in randomized clinical trials designed to meet typical one‐sided 2.5% α‐level and 80% power. This may not be achievable when the disease is rare. We simulated a series of two‐arm superiority trials over a 15‐year period. The design parameters examined were the α‐level and the number of trials conducted over the 15‐year period (thus, trial sample size). Different disease severities and accrual rates were considered. The future treatment effect was characterized by its associated hazard rate; different hypotheses of how treatments improve over time were considered. We defined the total survival benefit as the relative difference of the hazard rates at year 15 versus year 0. The optimal design was defined by maximizing the expected total survival benefit, provided that the risk of selecting at year 15 a treatment inferior to the initial control treatment remains below 1%. Compared with two larger trials with typical one‐sided 2.5% α‐level, performing a series of small trials with relaxed α‐levels leads on average to larger survival benefits over a 15‐year research horizon, but also to higher risk of selecting a worse treatment at the end of the research period. Under reasonably optimistic assumptions regarding the future treatment effects, optimal designs outperform traditional ones when the disease is severe (baseline median survival ≤ 1 year) and the accrual is ≥100 patients per year, whereas no major improvement is observed in diseases with better prognosis. Trial designs aiming to maximize survival gain over a long research horizon across a series of trials are worth discussing in the context of rare diseases. Copyright © 2016 John Wiley & Sons, Ltd.